Amedisys, Inc. (NASDAQ:AMED) Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund lessened its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 14.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,348 shares of the health services provider’s stock after selling 5,000 shares during the period. New York State Common Retirement Fund’s holdings in Amedisys were worth $2,885,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Commonwealth Equity Services LLC raised its stake in Amedisys by 2.9% in the third quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock valued at $364,000 after buying an additional 110 shares during the last quarter. Xponance Inc. grew its stake in shares of Amedisys by 3.2% during the third quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock worth $381,000 after acquiring an additional 125 shares during the last quarter. Arizona State Retirement System raised its position in shares of Amedisys by 1.5% in the 3rd quarter. Arizona State Retirement System now owns 9,284 shares of the health services provider’s stock valued at $867,000 after purchasing an additional 141 shares during the last quarter. Argonautica Private Wealth Management Inc. boosted its stake in Amedisys by 6.1% in the 3rd quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider’s stock worth $280,000 after purchasing an additional 172 shares in the last quarter. Finally, Paralel Advisors LLC boosted its stake in Amedisys by 1.1% in the 3rd quarter. Paralel Advisors LLC now owns 26,002 shares of the health services provider’s stock worth $2,429,000 after purchasing an additional 295 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on AMED. Royal Bank of Canada raised their price target on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, March 25th. Raymond James restated a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. StockNews.com raised Amedisys from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, April 25th. Seven investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Amedisys currently has an average rating of “Hold” and a consensus target price of $100.80.

Amedisys Stock Performance

Shares of AMED stock opened at $92.34 on Tuesday. The stock has a market cap of $3.02 billion, a PE ratio of -144.28, a price-to-earnings-growth ratio of 3.43 and a beta of 0.84. Amedisys, Inc. has a 52-week low of $73.10 and a 52-week high of $96.44. The business has a 50-day simple moving average of $92.36 and a 200-day simple moving average of $93.33. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.31.

Amedisys (NASDAQ:AMED) last announced its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. The company had revenue of $571.41 million during the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. Amedisys’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.00 earnings per share. On average, equities analysts expect that Amedisys, Inc. will post 4.57 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.